| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693467 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2017 | 7 Pages |
Abstract
Five-year therapy with NETA is safe and well tolerated by women with rectovaginal endometriosis. Due to its low cost and good pharmacological profile, it represents a good candidate for long-term treatment in this setting.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Matteo Morotti, Pier Luigi Venturini, Ennio Biscaldi, Annalisa Racca, Luana Calanni, Valerio Gaetano Vellone, Cesare Stabilini, Simone Ferrero,